Nephros Inc. (NEPH) NASDAQ

$2.19 (0.08) (-3.52%)

Market Cap: $23.93M

As of 03/28/24 04:00 PM EDT. Market closed.

(NEPH)

Nephros Inc. (NEPH)
NASDAQ

$2.19
(0.08) (-3.52%)

Market Cap: $23.93M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to ... read more

nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to optimize the three elements critical to filter performance: • filtration – as low as 5 nanometers • flow rate – minimal disruption • filter life – up to 12 months nephros was founded in 1997, by healthcare professionals affiliated with columbia university medical center, initially to address the needs of chronic renal failure patients. the company has developed an alternative to current hemodialysis therapy known as mid-dilution hemodiafiltration (mid-hdf). nephros’ proprietary blood purification technologies enable mid-hdf to be offered to chronic renal failure patients. nephros mid-dilution fil read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Full Time Employees
56
Address
.
PRICE CHART FOR NEPHROS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$2.27
Days Range
$2.24 - $2.33
52 week range
$1.05 - $4.04
Volume
3,277
Avg. Volume (30 days)
20,583
Market Cap
$23.93M
Dividend Yield
-
P/E
-
Shares Outstanding
10,543,675
Open
-
Previous Close
$2.27
Days Range
$2.24 - $2.33
52 week range
$1.05 - $4.04
Volume
3,277
Avg. Volume (30 days)
20,583
Market Cap
$23.93M
Dividend Yield
-
P/E
-
Shares Outstanding
10,543,675
FINANCIAL STATEMENTS FOR NEPHROS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR NEPHROS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Amron Arthur HDirectorMar 12, 2024 Buy$2.457,00017,1307,000Mar 14, 2024, 04:28 PM
Banks Robert R. Jr.President and CEODec 07, 2023 Buy$2.2018,00039,64720,000Dec 11, 2023, 04:17 PM
Banks Robert R. Jr.President and CEOAug 15, 2023 Buy$1.691,9013,2072,000Aug 15, 2023, 04:15 PM
Banks Robert R. Jr.President and CEOAug 14, 2023 Buy$1.509914999Aug 15, 2023, 04:15 PM
Astor AndrewPresident, CEO & CFOMar 05, 2022 Option Exercise$2.7014,81540,00192,773Mar 07, 2022, 05:44 PM
Lobo Wesley S.Chief Marketing OfficerFeb 16, 2022 Option Exercise$4.806,38930,66735,168Feb 18, 2022, 05:03 PM
Lobo Wesley S.Chief Marketing OfficerAug 20, 2021 Buy$7.921,0007,92041,557Aug 23, 2021, 01:01 PM
Gwydir TomDirectorAug 18, 2021 Buy$7.645,00038,20011,031Aug 19, 2021, 09:04 PM
Astor AndrewPresident & CEOAug 18, 2021 Buy$7.772,50019,43377,958Aug 18, 2021, 06:08 PM
Astor AndrewPresident & CEOAug 17, 2021 Buy$7.672,50019,17275,458Aug 18, 2021, 06:08 PM
Evans DaronCEO Specialty Renal ProductsMay 27, 2021 Option Exercise$2.703499428,669Jun 01, 2021, 05:39 PM
Evans DaronCEO Specialty Renal ProductsMay 27, 2021 Option Exercise$2.703499428,947Jun 01, 2021, 05:39 PM
Evans DaronCEO of Specialty Renal ProductMay 24, 2021 Option Exercise$2.701,1113,0009,018May 25, 2021, 03:40 PM
Evans DaronCEO of Specialty Renal ProductMay 24, 2021 Option Exercise$2.701,1113,0009,296May 25, 2021, 03:40 PM
WEXFORD CAPITAL LPDirectorJan 27, 2021 Option Exercise$4.2214,75462,260106,037Jan 29, 2021, 04:49 PM
Spandow Oliver J.DirectorNov 18, 2020 Buy$5.831,5008,74915,734Nov 20, 2020, 04:28 PM
Astor AndrewPresident & CEONov 19, 2020 Buy$5.871,0005,86772,958Nov 19, 2020, 06:17 PM
WEXFORD CAPITAL LPDirectorOct 15, 2020 Option Exercise$6.00166,6671,000,0023,605,471Oct 16, 2020, 04:38 PM
Astor AndrewCOO/CFOAug 19, 2020 Buy$7.409507,03071,958Aug 19, 2020, 06:22 PM
Astor AndrewCFO/COOMay 28, 2020 Buy$6.961,0006,96071,008May 29, 2020, 06:08 PM
PERSEN MALCOLM CDirectorMay 11, 2020 Option Exercise$7.651,73213,2505,194May 13, 2020, 04:56 PM
Evans DaronPresident and CEOMar 12, 2020 Buy$6.652,50016,625134,215Mar 12, 2020, 05:02 PM
Astor AndrewCFO/COOMar 12, 2020 Buy$6.701,0006,70070,008Mar 12, 2020, 04:50 PM
Evans DaronPresident and CEOMar 05, 2020 Buy$8.442,50021,109131,715Mar 05, 2020, 05:18 PM
Astor AndrewCFO/COOMar 05, 2020 Buy$8.467005,92069,008Mar 05, 2020, 05:10 PM
Spandow Oliver J.DirectorNov 25, 2019 Buy$8.171,0008,17010,786Nov 26, 2019, 04:25 PM
Astor AndrewCFO/COONov 18, 2019 Buy$8.387506,28261,460Nov 18, 2019, 12:13 PM
Evans DaronPresident and CEONov 18, 2019 Buy$8.351,0008,350119,933Nov 18, 2019, 12:12 PM
Lask AlisaDirectorSep 11, 2019 Buy$6.452501,612250Sep 13, 2019, 04:32 PM
Astor AndrewCFO/COOAug 22, 2019 Buy$6.971,50010,45560,710Aug 22, 2019, 04:37 PM
Evans DaronPresident and CEOAug 22, 2019 Buy$6.922,00013,845118,933Aug 22, 2019, 04:09 PM
Astor AndrewCFO/COOJun 14, 2019 Buy$0.6435,00022,400532,903Jun 14, 2019, 12:35 PM
Evans DaronPresident and CEOJun 14, 2019 Buy$0.588,0004,65373,666Jun 14, 2019, 12:34 PM
Evans DaronPresident and CEOJun 14, 2019 Buy$0.6011,1726,6831,052,426Jun 14, 2019, 12:34 PM
Evans DaronPresident and CEOJun 14, 2019 Buy$0.608,0004,8308,000Jun 14, 2019, 12:34 PM
Evans DaronPresident and CEOJun 14, 2019 Buy$0.618,0004,8758,000Jun 14, 2019, 12:34 PM
Evans DaronPresident and CEOJun 14, 2019 Buy$0.598,0004,72071,166Jun 14, 2019, 12:34 PM
Astor AndrewChief Financial OfficerMay 14, 2018 Option Exercise$0.3033,33310,000453,792May 14, 2018, 04:44 PM
Evans DaronPresident and CEOMay 14, 2018 Option Exercise$0.3040,00012,00095,000May 14, 2018, 07:27 AM
Evans DaronPresident and CEOApr 10, 2018 Buy$0.4512,0005,40065,666Apr 12, 2018, 04:12 PM
Evans DaronPresident and CEOApr 10, 2018 Buy$0.4555,00024,75055,000Apr 12, 2018, 04:12 PM
Evans DaronPresident and CEOApr 10, 2018 Buy$0.4512,0005,40063,166Apr 12, 2018, 04:12 PM
Astor AndrewChief Financial OfficerApr 10, 2018 Buy$0.4580,00036,000420,459Apr 12, 2018, 04:11 PM
Astor AndrewChief Financial OfficerMar 09, 2018 Buy$0.475,0002,375340,459Mar 13, 2018, 04:08 PM
Astor AndrewChief Financial OfficerDec 04, 2017 Buy$0.508,3334,167215,042Dec 05, 2017, 04:17 PM
Astor AndrewChief Financial OfficerDec 01, 2017 Buy$0.5010,0005,000206,709Dec 05, 2017, 04:17 PM
Evans DaronPresident and CEOSep 06, 2017 Buy$0.2428,0006,818712,958Sep 06, 2017, 05:13 PM
Evans DaronPresident and CEOSep 05, 2017 Buy$0.231,580371684,958Sep 06, 2017, 05:13 PM
Astor AndrewChief Financial OfficerJun 16, 2017 Option Exercise$0.264311186,709Aug 28, 2017, 04:53 PM
Astor AndrewChief Financial OfficerAug 28, 2017 Buy$0.2710,0002,712196,709Aug 28, 2017, 04:53 PM
Evans DaronPresident and CEOAug 22, 2017 Buy$0.252,00050051,166Aug 23, 2017, 12:51 PM
Evans DaronPresident and CEOAug 22, 2017 Buy$0.252,00050053,666Aug 23, 2017, 12:51 PM
Evans DaronPresident and CEOAug 11, 2017 Buy$0.2670,00018,200683,378Aug 11, 2017, 05:35 PM
Astor AndrewChief Financial OfficerAug 11, 2017 Buy$0.2620,0005,198186,666Aug 11, 2017, 05:35 PM
Evans DaronPresident and CEOJun 09, 2017 Buy$0.267,5001,95049,166Jun 13, 2017, 04:19 PM
Evans DaronPresident and CEOJun 09, 2017 Buy$0.2610,0002,60051,666Jun 13, 2017, 04:19 PM
Evans DaronPresident and CEOJun 12, 2017 Buy$0.263,9611,030613,378Jun 13, 2017, 04:19 PM
Evans DaronPresident and CEOMay 19, 2017 Buy$0.257,5001,912609,417May 19, 2017, 05:55 PM
Evans DaronPresident and CEOMay 18, 2017 Buy$0.2522,5005,737601,917May 19, 2017, 05:55 PM
Evans DaronPresident and CEODec 07, 2016 Buy$0.324,0691,302339,428Dec 09, 2016, 05:11 PM
Evans DaronPresident and CEODec 05, 2016 Buy$0.3410,6203,610335,359Dec 06, 2016, 04:37 PM
Evans DaronPresident and CEODec 01, 2016 Buy$0.3240,59913,016324,739Dec 02, 2016, 04:28 PM
Evans DaronPresident and CEONov 30, 2016 Buy$0.29931270284,140Dec 02, 2016, 04:28 PM
Evans DaronPresident and CEOAug 31, 2015 Buy$0.5710,0005,700169,759Aug 31, 2015, 04:24 PM
Evans DaronPresident and CEOAug 28, 2015 Buy$0.5915,0008,900159,759Aug 31, 2015, 04:24 PM
Evans DaronPresident and CEOAug 27, 2015 Buy$0.5619,17510,738144,759Aug 31, 2015, 04:24 PM
Evans DaronPresident and CEOAug 20, 2015 Buy$0.5627,00015,120125,584Aug 20, 2015, 06:43 PM
Evans DaronPresident and CEOAug 19, 2015 Buy$0.5024,50012,25098,584Aug 20, 2015, 06:43 PM
CENTELLA LAWRENCE JDirectorDec 18, 2014 Option Exercise$0.6010,2026,121121,332Dec 22, 2014, 06:39 PM
ROSENBERG MATTHEWDirectorDec 18, 2014 Option Exercise$0.60374,997224,998589,695Dec 22, 2014, 05:57 PM
Houghton John C.President, CEO and Acting CFODec 18, 2014 Option Exercise$0.607,8854,73174,139Dec 22, 2014, 05:56 PM
Evans DaronDirectorDec 18, 2014 Option Exercise$0.6021,23912,74374,084Dec 22, 2014, 05:53 PM
Evans DaronDirectorMar 21, 2014 Option Exercise$0.302,1516459,651Mar 27, 2014, 04:45 PM
CENTELLA LAWRENCE JDirectorMar 21, 2014 Option Exercise$0.3019,1055,73285,735Mar 24, 2014, 05:22 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Amron Arthur HDirector03/12/202417,130
Banks Robert R. Jr.President and CEO12/07/202339,647
Banks Robert R. Jr.President and CEO08/15/20233,207
Banks Robert R. Jr.President and CEO08/14/2023149
Astor AndrewPresident, CEO & CFO03/05/202240,001
Lobo Wesley S.Chief Marketing Officer02/16/202230,667
Lobo Wesley S.Chief Marketing Officer08/20/20217,920
Gwydir TomDirector08/18/202138,200
Astor AndrewPresident & CEO08/18/202119,433
Astor AndrewPresident & CEO08/17/202119,172
Evans DaronCEO Specialty Renal Products05/27/2021942
Evans DaronCEO Specialty Renal Products05/27/2021942
Evans DaronCEO of Specialty Renal Product05/24/20213,000
Evans DaronCEO of Specialty Renal Product05/24/20213,000
WEXFORD CAPITAL LPDirector01/27/202162,260
Spandow Oliver J.Director11/18/20208,749
Astor AndrewPresident & CEO11/19/20205,867
WEXFORD CAPITAL LPDirector10/15/20201,000,002
Astor AndrewCOO/CFO08/19/20207,030
Astor AndrewCFO/COO05/28/20206,960
PERSEN MALCOLM CDirector05/11/202013,250
Evans DaronPresident and CEO03/12/202016,625
Astor AndrewCFO/COO03/12/20206,700
Evans DaronPresident and CEO03/05/202021,109
Astor AndrewCFO/COO03/05/20205,920
Spandow Oliver J.Director11/25/20198,170
Astor AndrewCFO/COO11/18/20196,282
Evans DaronPresident and CEO11/18/20198,350
Lask AlisaDirector09/11/20191,612
Astor AndrewCFO/COO08/22/201910,455
Evans DaronPresident and CEO08/22/201913,845
Astor AndrewCFO/COO06/14/201922,400
Evans DaronPresident and CEO06/14/20194,653
Evans DaronPresident and CEO06/14/20196,683
Evans DaronPresident and CEO06/14/20194,830
Evans DaronPresident and CEO06/14/20194,875
Evans DaronPresident and CEO06/14/20194,720
Astor AndrewChief Financial Officer05/14/201810,000
Evans DaronPresident and CEO05/14/201812,000
Evans DaronPresident and CEO04/10/20185,400
Evans DaronPresident and CEO04/10/201824,750
Evans DaronPresident and CEO04/10/20185,400
Astor AndrewChief Financial Officer04/10/201836,000
Astor AndrewChief Financial Officer03/09/20182,375
Astor AndrewChief Financial Officer12/04/20174,167
Astor AndrewChief Financial Officer12/01/20175,000
Evans DaronPresident and CEO09/06/20176,818
Evans DaronPresident and CEO09/05/2017371
Astor AndrewChief Financial Officer06/16/201711
Astor AndrewChief Financial Officer08/28/20172,712
Evans DaronPresident and CEO08/22/2017500
Evans DaronPresident and CEO08/22/2017500
Evans DaronPresident and CEO08/11/201718,200
Astor AndrewChief Financial Officer08/11/20175,198
Evans DaronPresident and CEO06/09/20171,950
Evans DaronPresident and CEO06/09/20172,600
Evans DaronPresident and CEO06/12/20171,030
Evans DaronPresident and CEO05/19/20171,912
Evans DaronPresident and CEO05/18/20175,737
Evans DaronPresident and CEO12/07/20161,302
Evans DaronPresident and CEO12/05/20163,610
Evans DaronPresident and CEO12/01/201613,016
Evans DaronPresident and CEO11/30/2016270
Evans DaronPresident and CEO08/31/20155,700
Evans DaronPresident and CEO08/28/20158,900
Evans DaronPresident and CEO08/27/201510,738
Evans DaronPresident and CEO08/20/201515,120
Evans DaronPresident and CEO08/19/201512,250
CENTELLA LAWRENCE JDirector12/18/20146,121
ROSENBERG MATTHEWDirector12/18/2014224,998
Houghton John C.President, CEO and Acting CFO12/18/20144,731
Evans DaronDirector12/18/201412,743
Evans DaronDirector03/21/2014645
CENTELLA LAWRENCE JDirector03/21/20145,732
Load More Insider Transactions
FUNDS WITH A POSITION IN NEPHROS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC71,0370.00003%No changeOther
BLACKROCK INC.4,1310%No changeOther
CHANGE IN SHARES OUTSTANDING FOR NEPHROS INC
STOCK BUYBACKS FOR NEPHROS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.26%
1Q
12/31/2023
06/30/2023
1.85%
2Q
12/31/2023
03/31/2023
1.85%
3Q
12/31/2023
12/31/2022
1.29%
4Q
12/31/2023
09/30/2022
1.79%
5Q
12/31/2023
06/30/2022
1.83%
6Q
12/31/2023
03/31/2022
2.68%
7Q
12/31/2023
12/31/2021
2.83%
8Q
12/31/2023
09/30/2021
4.41%
9Q
12/31/2023
06/30/2021
5.48%
10Q
12/31/2023
03/31/2021
6.12%
11Q
12/31/2023
12/31/2020
8.16%
12Q
12/31/2023
09/30/2020
16.02%
13Q
12/31/2023
06/30/2020
16.71%
14Q
12/31/2023
03/31/2020
22.09%
15Q
12/31/2023
12/31/2019
32.03%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.26%
1Q
06/30/2023
1.85%
2Q
03/31/2023
1.85%
3Q
12/31/2022
1.29%
4Q
09/30/2022
1.79%
5Q
06/30/2022
1.83%
6Q
03/31/2022
2.68%
7Q
12/31/2021
2.83%
8Q
09/30/2021
4.41%
9Q
06/30/2021
5.48%
10Q
03/31/2021
6.12%
11Q
12/31/2020
8.16%
12Q
09/30/2020
16.02%
13Q
06/30/2020
16.71%
14Q
03/31/2020
22.09%
15Q
12/31/2019
32.03%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NEPHROS INC
LOADING...